Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 60 entries
Sorted by: Best Match Show Resources per page
Polyclonal Bence Jones Proteinuria Associated with Reactive Plasmacytosis.

Leukemia & lymphoma

Tarlton SW, Ariad S, Lewis D, Rowe P, Mendelow BV.
PMID: 27457302
Leuk Lymphoma. 1990;3(2):151-6. doi: 10.3109/10428199009050990.

A 43 year old black male patient presented with progressive respiratory symptoms, fever and malaise of short duration accompanied by mild epistaxis. Physical examination revealed generalised lymphadenopathy and hepatosplenomegaly. Peripheral blood examination showed a striking plasmacytosis. Further investigation revealed...

Cite
Tarlton SW, Ariad S, Lewis D, et al. Polyclonal Bence Jones Proteinuria Associated with Reactive Plasmacytosis. Leuk Lymphoma. 1990;3(2):151-6doi: 10.3109/10428199009050990.
Tarlton, S. W., Ariad, S., Lewis, D., Rowe, P., & Mendelow, B. V. (1990). Polyclonal Bence Jones Proteinuria Associated with Reactive Plasmacytosis. Leukemia & lymphoma, 3(2), 151-6. https://doi.org/10.3109/10428199009050990
Tarlton, S W, et al. "Polyclonal Bence Jones Proteinuria Associated with Reactive Plasmacytosis." Leukemia & lymphoma vol. 3,2 (1990): 151-6. doi: https://doi.org/10.3109/10428199009050990
Tarlton SW, Ariad S, Lewis D, Rowe P, Mendelow BV. Polyclonal Bence Jones Proteinuria Associated with Reactive Plasmacytosis. Leuk Lymphoma. 1990;3(2):151-6. doi: 10.3109/10428199009050990. PMID: 27457302.
Copy Download .nbib Format: NLM
Prognostic factors associated with solitary plasmacytoma.

OncoTargets and therapy

Guo SQ, Zhang L, Wang YF, Sun BC, Zhang LY, Zhang J, Wang G, Zhang YZ.
PMID: 24259986
Onco Targets Ther. 2013 Nov 14;6:1659-66. doi: 10.2147/OTT.S53248. eCollection 2013.

Solitary plasmacytoma (SP) is a rare tumor with low incidence. The aim of this study was to investigate the clinical features, treatment strategies, and relative prognostic factors of 66 patients with SP. These patients made up 10.25% of the...

Cite
Guo SQ, Zhang L, Wang YF, et al. Prognostic factors associated with solitary plasmacytoma. Onco Targets Ther. 2013;6:1659-66doi: 10.2147/OTT.S53248.
Guo, S. Q., Zhang, L., Wang, Y. F., Sun, B. C., Zhang, L. Y., Zhang, J., Wang, G., & Zhang, Y. Z. (2013). Prognostic factors associated with solitary plasmacytoma. OncoTargets and therapy, 61659-66. https://doi.org/10.2147/OTT.S53248
Guo, Shan-Qi, et al. "Prognostic factors associated with solitary plasmacytoma." OncoTargets and therapy vol. 6 (2013): 1659-66. doi: https://doi.org/10.2147/OTT.S53248
Guo SQ, Zhang L, Wang YF, Sun BC, Zhang LY, Zhang J, Wang G, Zhang YZ. Prognostic factors associated with solitary plasmacytoma. Onco Targets Ther. 2013 Nov 14;6:1659-66. doi: 10.2147/OTT.S53248. eCollection 2013. PMID: 24259986; PMCID: PMC3833869.
Copy Download .nbib Format: NLM
Disseminated plasma cell myeloma presenting as massive pleural effusion.

European clinical respiratory journal

Babu KA, Sundararajan L, Prabu P, Parameswaran A.
PMID: 26664659
Eur Clin Respir J. 2015 Nov 24;2. doi: 10.3402/ecrj.v2.27028. eCollection 2015.

Plasma cell myeloma (PCM) is a hematologic malignancy of plasma cell origin and usually associated with the presence of lytic bone lesions. Pleural effusions are rarely associated with PCM and most often signify a concurrent disease process. Malignant myelomatous...

Cite
Babu KA, Sundararajan L, Prabu P, et al. Disseminated plasma cell myeloma presenting as massive pleural effusion. Eur Clin Respir J. 2015;2doi: 10.3402/ecrj.v2.27028.
Babu, K. A., Sundararajan, L., Prabu, P., & Parameswaran, A. (2015). Disseminated plasma cell myeloma presenting as massive pleural effusion. European clinical respiratory journal, 2. https://doi.org/10.3402/ecrj.v2.27028
Babu, Kanahasubramanian Anand, et al. "Disseminated plasma cell myeloma presenting as massive pleural effusion." European clinical respiratory journal vol. 2 (2015). doi: https://doi.org/10.3402/ecrj.v2.27028
Babu KA, Sundararajan L, Prabu P, Parameswaran A. Disseminated plasma cell myeloma presenting as massive pleural effusion. Eur Clin Respir J. 2015 Nov 24;2. doi: 10.3402/ecrj.v2.27028. eCollection 2015. PMID: 26664659; PMCID: PMC4660938.
Copy Download .nbib Format: NLM
The Nitrogen-Distribution in Bence-Jones' Protein, with a Note upon a New Colorimetric Method for Tryptophan-Estimation in Protein.

The Biochemical journal

Lüscher E.
PMID: 16743116
Biochem J. 1922;16(5):556-63. doi: 10.1042/bj0160556.

No abstract available.

Cite
Lüscher E. The Nitrogen-Distribution in Bence-Jones' Protein, with a Note upon a New Colorimetric Method for Tryptophan-Estimation in Protein. Biochem J. 1922;16(5):556-63doi: 10.1042/bj0160556.
Lüscher, E. (1922). The Nitrogen-Distribution in Bence-Jones' Protein, with a Note upon a New Colorimetric Method for Tryptophan-Estimation in Protein. The Biochemical journal, 16(5), 556-63. https://doi.org/10.1042/bj0160556
Lüscher, E. "The Nitrogen-Distribution in Bence-Jones' Protein, with a Note upon a New Colorimetric Method for Tryptophan-Estimation in Protein." The Biochemical journal vol. 16,5 (1922): 556-63. doi: https://doi.org/10.1042/bj0160556
Lüscher E. The Nitrogen-Distribution in Bence-Jones' Protein, with a Note upon a New Colorimetric Method for Tryptophan-Estimation in Protein. Biochem J. 1922;16(5):556-63. doi: 10.1042/bj0160556. PMID: 16743116; PMCID: PMC1259110.
Copy Download .nbib Format: NLM
Immunological differences of crystalline Bence-Jones proteins.

The Biochemical journal

Hektoen L, Welker WH.
PMID: 16747184
Biochem J. 1940 Apr;34(4):487-9. doi: 10.1042/bj0340487.

No abstract available.

Cite
Hektoen L, Welker WH. Immunological differences of crystalline Bence-Jones proteins. Biochem J. 1940;34(4):487-9doi: 10.1042/bj0340487.
Hektoen, L., & Welker, W. H. (1940). Immunological differences of crystalline Bence-Jones proteins. The Biochemical journal, 34(4), 487-9. https://doi.org/10.1042/bj0340487
Hektoen, L, and Welker, W H. "Immunological differences of crystalline Bence-Jones proteins." The Biochemical journal vol. 34,4 (1940): 487-9. doi: https://doi.org/10.1042/bj0340487
Hektoen L, Welker WH. Immunological differences of crystalline Bence-Jones proteins. Biochem J. 1940 Apr;34(4):487-9. doi: 10.1042/bj0340487. PMID: 16747184; PMCID: PMC1265304.
Copy Download .nbib Format: NLM
An analysis of Bence-Jones protein.

The Biochemical journal

Devine J.
PMID: 16747340
Biochem J. 1941 Mar;35(3):433-45. doi: 10.1042/bj0350433.

No abstract available.

Cite
Devine J. An analysis of Bence-Jones protein. Biochem J. 1941;35(3):433-45doi: 10.1042/bj0350433.
Devine, J. (1941). An analysis of Bence-Jones protein. The Biochemical journal, 35(3), 433-45. https://doi.org/10.1042/bj0350433
Devine, J. "An analysis of Bence-Jones protein." The Biochemical journal vol. 35,3 (1941): 433-45. doi: https://doi.org/10.1042/bj0350433
Devine J. An analysis of Bence-Jones protein. Biochem J. 1941 Mar;35(3):433-45. doi: 10.1042/bj0350433. PMID: 16747340; PMCID: PMC1265508.
Copy Download .nbib Format: NLM
Markers of tumor burden : an overview.

Methods in molecular medicine

Roulston JE.
PMID: 21340761
Methods Mol Med. 2001;39:109-20. doi: 10.1385/1-59259-071-3:109.

Since ancient times, cancer has been known to humankind. The ancient Greeks and Romans have left us with writings in which various treatment options are discussed (1). Disease processes and causes were not well understood, however; the humoral pathology...

Cite
Roulston JE. Markers of tumor burden : an overview. Methods Mol Med. 2001;39:109-20doi: 10.1385/1-59259-071-3:109.
Roulston, J. E. (2001). Markers of tumor burden : an overview. Methods in molecular medicine, 39109-20. https://doi.org/10.1385/1-59259-071-3:109
Roulston, J E. "Markers of tumor burden : an overview." Methods in molecular medicine vol. 39 (2001): 109-20. doi: https://doi.org/10.1385/1-59259-071-3:109
Roulston JE. Markers of tumor burden : an overview. Methods Mol Med. 2001;39:109-20. doi: 10.1385/1-59259-071-3:109. PMID: 21340761.
Copy Download .nbib Format: NLM
CLASSIFICATION OF MYELOMA PROTEINS, BENCE JONES PROTEINS, AND MACROGLOBULINS INTO TWO GROUPS ON THE BASIS OF COMMON ANTIGENIC CHARACTERS.

The Journal of experimental medicine

Mannik M, Kunkel HG.
PMID: 19867218
J Exp Med. 1962 Nov 30;116(6):859-77. doi: 10.1084/jem.116.6.859.

Antisera to normal 7S gamma-globulin and to Bence Jones proteins permit the grouping of myeloma proteins (gamma and beta 2A types), Bence Jones proteins, and the Waldenström type macroglobulins into two fundamental antigenic groups. The antigenic determinants responsible for...

Cite
Mannik M, Kunkel HG. CLASSIFICATION OF MYELOMA PROTEINS, BENCE JONES PROTEINS, AND MACROGLOBULINS INTO TWO GROUPS ON THE BASIS OF COMMON ANTIGENIC CHARACTERS. J Exp Med. 1962;116(6):859-77doi: 10.1084/jem.116.6.859.
Mannik, M., & Kunkel, H. G. (1962). CLASSIFICATION OF MYELOMA PROTEINS, BENCE JONES PROTEINS, AND MACROGLOBULINS INTO TWO GROUPS ON THE BASIS OF COMMON ANTIGENIC CHARACTERS. The Journal of experimental medicine, 116(6), 859-77. https://doi.org/10.1084/jem.116.6.859
Mannik, M, and Kunkel, H G. "CLASSIFICATION OF MYELOMA PROTEINS, BENCE JONES PROTEINS, AND MACROGLOBULINS INTO TWO GROUPS ON THE BASIS OF COMMON ANTIGENIC CHARACTERS." The Journal of experimental medicine vol. 116,6 (1962): 859-77. doi: https://doi.org/10.1084/jem.116.6.859
Mannik M, Kunkel HG. CLASSIFICATION OF MYELOMA PROTEINS, BENCE JONES PROTEINS, AND MACROGLOBULINS INTO TWO GROUPS ON THE BASIS OF COMMON ANTIGENIC CHARACTERS. J Exp Med. 1962 Nov 30;116(6):859-77. doi: 10.1084/jem.116.6.859. PMID: 19867218; PMCID: PMC2137582.
Copy Download .nbib Format: NLM
Multiple myeloma presenting as an intracranial plasmacytoma: a case report.

Cases journal

Terada T.
PMID: 20062687
Cases J. 2009 Nov 30;2:9110. doi: 10.1186/1757-1626-2-9110.

Multiple myeloma presenting as an intracranial tumor (plasmacytoma) is very rare. An 81-year-old woman was admitted to our hospital because of gait disturbance. A blood laboratory test revealed a mildly increased lactate dehydrogenase (236 IU/L) and glucose (121 mg/dl)....

Cite
Terada T. Multiple myeloma presenting as an intracranial plasmacytoma: a case report. Cases J. 2009;2:9110doi: 10.1186/1757-1626-2-9110.
Terada, T. (2009). Multiple myeloma presenting as an intracranial plasmacytoma: a case report. Cases journal, 29110. https://doi.org/10.1186/1757-1626-2-9110
Terada, Tadashi. "Multiple myeloma presenting as an intracranial plasmacytoma: a case report." Cases journal vol. 2 (2009): 9110. doi: https://doi.org/10.1186/1757-1626-2-9110
Terada T. Multiple myeloma presenting as an intracranial plasmacytoma: a case report. Cases J. 2009 Nov 30;2:9110. doi: 10.1186/1757-1626-2-9110. PMID: 20062687; PMCID: PMC2803907.
Copy Download .nbib Format: NLM
A Case of Light Chain Deposition Disease (LCDD) in a Young Patient.

Indian journal of clinical biochemistry : IJCB

Mahto M, Mohapatra S, Sumitra G, Kaushik S, Mishra TK, Saxena A.
PMID: 23024482
Indian J Clin Biochem. 2011 Oct;26(4):420-2. doi: 10.1007/s12291-010-0105-z. Epub 2011 Jan 11.

Light chain disease is a variant of multiple myeloma in which the malignant population of marrow cells produces free monoclonal light chains but no heavy chain or complete immunoglobulin. The monoclonal light chains are small enough to be freely...

Cite
Mahto M, Mohapatra S, Sumitra G, et al. A Case of Light Chain Deposition Disease (LCDD) in a Young Patient. Indian J Clin Biochem. 2011;26(4):420-2doi: 10.1007/s12291-010-0105-z.
Mahto, M., Mohapatra, S., Sumitra, G., Kaushik, S., Mishra, T. K., & Saxena, A. (2011). A Case of Light Chain Deposition Disease (LCDD) in a Young Patient. Indian journal of clinical biochemistry : IJCB, 26(4), 420-2. https://doi.org/10.1007/s12291-010-0105-z
Mahto, Mala, et al. "A Case of Light Chain Deposition Disease (LCDD) in a Young Patient." Indian journal of clinical biochemistry : IJCB vol. 26,4 (2011): 420-2. doi: https://doi.org/10.1007/s12291-010-0105-z
Mahto M, Mohapatra S, Sumitra G, Kaushik S, Mishra TK, Saxena A. A Case of Light Chain Deposition Disease (LCDD) in a Young Patient. Indian J Clin Biochem. 2011 Oct;26(4):420-2. doi: 10.1007/s12291-010-0105-z. Epub 2011 Jan 11. PMID: 23024482; PMCID: PMC3210242.
Copy Download .nbib Format: NLM
Late-onset Familial Amyloidotic Polyneuropathy with Bence Jones Proteinuria and Cardiomyopathy.

Journal of neurosciences in rural practice

García de León SC, González AH, Alonso CO, Lobo LB.
PMID: 28694632
J Neurosci Rural Pract. 2017 Jul-Sep;8(3):448-450. doi: 10.4103/jnrp.jnrp_498_16.

Familial amyloidotic polyneuropathy is a genetically determined disease characterized by deposition of an anomalous transthyretin. A high index of suspicion is needed for this multisymptomatic and lethal disease to be diagnosed. The patient was a 70-year-old male examined due...

Cite
García de León SC, González AH, Alonso CO, et al. Late-onset Familial Amyloidotic Polyneuropathy with Bence Jones Proteinuria and Cardiomyopathy. J Neurosci Rural Pract. 2017;8(3):448-450doi: 10.4103/jnrp.jnrp_498_16.
García de León, S. C., González, A. H., Alonso, C. O., & Lobo, L. B. (2017). Late-onset Familial Amyloidotic Polyneuropathy with Bence Jones Proteinuria and Cardiomyopathy. Journal of neurosciences in rural practice, 8(3), 448-450. https://doi.org/10.4103/jnrp.jnrp_498_16
García de León, Sira Carrasco, et al. "Late-onset Familial Amyloidotic Polyneuropathy with Bence Jones Proteinuria and Cardiomyopathy." Journal of neurosciences in rural practice vol. 8,3 (2017): 448-450. doi: https://doi.org/10.4103/jnrp.jnrp_498_16
García de León SC, González AH, Alonso CO, Lobo LB. Late-onset Familial Amyloidotic Polyneuropathy with Bence Jones Proteinuria and Cardiomyopathy. J Neurosci Rural Pract. 2017 Jul-Sep;8(3):448-450. doi: 10.4103/jnrp.jnrp_498_16. PMID: 28694632; PMCID: PMC5488573.
Copy Download .nbib Format: NLM
Light Chain Deposition Disease Diagnosed Using Computed Tomography-Guided Kidney Biopsy.

Cureus

Shimamura Y, Ogawa Y, Takizawa H, Hayashi T, Sakurai Y.
PMID: 34159010
Cureus. 2021 May 18;13(5):e15102. doi: 10.7759/cureus.15102.

Light chain deposition disease (LCDD) is characterized by the deposition of monoclonal immunoglobulin light chains in the kidney, which can cause end-stage kidney disease if not treated. While kidney biopsy is required for definitive diagnosis, choosing an appropriate biopsy...

Cite
Shimamura Y, Ogawa Y, Takizawa H, et al. Light Chain Deposition Disease Diagnosed Using Computed Tomography-Guided Kidney Biopsy. Cureus. 2021;13(5):e15102doi: 10.7759/cureus.15102.
Shimamura, Y., Ogawa, Y., Takizawa, H., Hayashi, T., & Sakurai, Y. (2021). Light Chain Deposition Disease Diagnosed Using Computed Tomography-Guided Kidney Biopsy. Cureus, 13(5), e15102. https://doi.org/10.7759/cureus.15102
Shimamura, Yoshinosuke, et al. "Light Chain Deposition Disease Diagnosed Using Computed Tomography-Guided Kidney Biopsy." Cureus vol. 13,5 (2021): e15102. doi: https://doi.org/10.7759/cureus.15102
Shimamura Y, Ogawa Y, Takizawa H, Hayashi T, Sakurai Y. Light Chain Deposition Disease Diagnosed Using Computed Tomography-Guided Kidney Biopsy. Cureus. 2021 May 18;13(5):e15102. doi: 10.7759/cureus.15102. PMID: 34159010; PMCID: PMC8212893.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 60 entries